United States Biotechnology & Medical Research

Anthera Pharmaceuticals Inc (ANTH)

Track

Track

Ticker: ANTH Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
THOMPSON JOHN CRAIG President & CEO
Transaction date
Purchase
Price
424.26
Quantity 98,633 +48.6%
Value US$1,842,586
TRUEX PAUL F
Transaction date
Purchase
Price
351.45
Quantity 13,416 +12.1%
Value US$3,455,945
Hislop Colin Chief Medical Officer Officer
Transaction date
Planned sale
Price
376.35
Quantity 87,810 -28.3%
Value US$3,798,842
Hislop Colin Chief Medical Officer Officer
Transaction date
Sale
Price
5.38
Quantity 5,000 -20.7%
Value US$26,900
Thompson David E. Non-Executive Director
Transaction date
Purchase
Price
0.53
Quantity 100,000 +354.6%
Value US$53,000
DZIURZYNSKI BOGDAN Non-Executive Director
Transaction date
Purchase
Price
0.59
Quantity 10,000 +inf%
Value US$5,900
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Purchase
Price
0.66
Quantity 5,700,000 +323.5%
Value US$3,762,000
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Purchase
Price
0.65
Quantity 1,762,000 +inf%
Value US$1,142,481
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
0.73
Quantity 1,283,300 -100.0%
Value US$942,071
HENNEY CHRISTOPHER S Non-Executive Director
Transaction date
Purchase
Price
0.75
Quantity 100,000 +inf%
Value US$74,930
HENNEY CHRISTOPHER S Non-Executive Director
Transaction date
Purchase
Price
0.75
Quantity 100,000 +97.6%
Value US$74,930
TRUEX PAUL F President and CEO Executive Director
Transaction date
Purchase
Price
0.76
Quantity 20,000 +3.2%
Value US$15,200
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
2.40
Quantity 1,306,700 -50.5%
Value US$3,140,131
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
2.87
Quantity 125,000 -4.6%
Value US$358,312
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
2.90
Quantity 116,800 -4.1%
Value US$338,638
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.23
Quantity 280 -0.6%
Value US$1,743
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.23
Quantity 4,090 -0.6%
Value US$25,460
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.23
Quantity 280 -0.6%
Value US$1,743
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.23
Quantity 4,090 -0.6%
Value US$25,460
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.23
Quantity 20,630 -0.6%
Value US$128,422
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.23
Quantity 20,630 -0.6%
Value US$128,422
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.22
Quantity 280 -0.6%
Value US$1,743
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.22
Quantity 4,090 -0.6%
Value US$25,457
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.22
Quantity 20,630 -0.6%
Value US$128,405
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.22
Quantity 280 -0.6%
Value US$1,743
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.22
Quantity 4,090 -0.6%
Value US$25,457
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.22
Quantity 20,630 -0.6%
Value US$128,405
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.51
Quantity 280 -0.6%
Value US$1,823
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.51
Quantity 4,090 -0.6%
Value US$26,629
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.51
Quantity 280 -0.6%
Value US$1,823
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.51
Quantity 4,090 -0.6%
Value US$26,629
HEALY JAMES Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.51
Quantity 20,630 -0.6%
Value US$134,318
SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
Transaction date
Sale
Price
6.51
Quantity 20,630 -0.6%
Value US$134,318
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
6.50
Quantity 16,200 -0.6%
Value US$105,300
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
6.75
Quantity 40,000 -1.4%
Value US$270,000
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.50
Quantity 3,000 -0.1%
Value US$19,500
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.67
Quantity 24,000 -0.8%
Value US$160,080
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.87
Quantity 25,000 -0.9%
Value US$171,750
TRUEX PAUL F President and CEO Executive Director
Transaction date
Planned sale
Price
6.96
Quantity 15,000 -2.2%
Value US$104,352
TRUEX PAUL F President and CEO Executive Director
Transaction date
Planned sale
Price
6.96
Quantity 15,000 -2.2%
Value US$104,352
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.93
Quantity 50,000 -1.7%
Value US$346,500
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.95
Quantity 5,000 -0.2%
Value US$34,750
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
7.14
Quantity 5,000 -0.2%
Value US$35,700
Hislop Colin Chief Medical Officer Officer
Transaction date
Sale
Price
6.74
Quantity 15,000 -20.6%
Value US$101,163
TRUEX PAUL F President and CEO Executive Director
Transaction date
Planned sale
Price
6.25
Quantity 11,879 -1.8%
Value US$74,244
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Officer
Transaction date
Planned sale
Price
7.93
Quantity 300 -6.1%
Value US$2,378
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 10 -0.1%
Value US$87
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 281 -0.1%
Value US$2,436
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 2,809 -0.1%
Value US$24,354
TRUEX PAUL F President and CEO Executive Director
Transaction date
Planned sale
Price
8.30
Quantity 15,000 -2.2%
Value US$124,539
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.81
Quantity 2 -0.0%
Value US$18
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.81
Quantity 63 -0.0%
Value US$555
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.81
Quantity 634 -0.0%
Value US$5,586
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.80
Quantity 4 -0.0%
Value US$35
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.80
Quantity 118 -0.0%
Value US$1,038
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.80
Quantity 1,178 -0.0%
Value US$10,366
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
8.18
Quantity 30,000 -1.0%
Value US$245,400
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
8.11
Quantity 37,000 -1.2%
Value US$300,070
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
8.02
Quantity 33,000 -1.1%
Value US$264,660
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.60
Quantity 16 -0.1%
Value US$138
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.60
Quantity 435 -0.1%
Value US$3,741
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.60
Quantity 4,349 -0.1%
Value US$37,401
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
8.65
Quantity 4,800
Value US$41,520
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 108 -0.6%
Value US$936
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 2,970 -0.6%
Value US$25,750
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.67
Quantity 29,672 -0.6%
Value US$257,256
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.42
Quantity 172 -1.0%
Value US$1,448
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.42
Quantity 4,734 -1.0%
Value US$39,860
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.42
Quantity 47,290 -1.0%
Value US$398,182
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.18
Quantity 88 -0.5%
Value US$720
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.18
Quantity 2,422 -0.5%
Value US$19,812
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.18
Quantity 24,193 -0.5%
Value US$197,899
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.03
Quantity 412 -2.2%
Value US$3,308
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.03
Quantity 11,337 -2.2%
Value US$91,036
VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
Transaction date
Sale
Price
8.03
Quantity 113,251 -2.2%
Value US$909,406
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-09-20 2017-09-20 B Purchase THOMPSON JOHN CRAIG

President & CEO
98,633 +48.6%
424.26
US$1,842,586 		98,633 +48.6% 424.26 US$1,842,586
2017-09-07 2017-09-07 B Purchase TRUEX PAUL F
13,416 +12.1%
351.45
US$3,455,945 		13,416 +12.1% 351.45 US$3,455,945
2015-11-18 2015-11-13 PlS Planned sale Hislop Colin

Chief Medical Officer

Officer
87,810 -28.3%
376.35
US$3,798,842 		87,810 -28.3% 376.35 US$3,798,842
2015-11-12 2015-11-11 S Sale Hislop Colin

Chief Medical Officer

Officer
5,000 -20.7%
5.38
US$26,900 		5,000 -20.7% 5.38 US$26,900
2013-06-26 2013-06-24 B Purchase Thompson David E. Non-Executive Director
100,000 +354.6%
0.53
US$53,000 		100,000 +354.6% 0.53 US$53,000
2013-06-04 2013-05-31 B Purchase DZIURZYNSKI BOGDAN Non-Executive Director
10,000 +inf%
0.59
US$5,900 		10,000 +inf% 0.59 US$5,900
2013-02-01 2013-01-30 B Purchase ORBIMED ADVISORS LLC Non-Executive Director
5,700,000 +323.5%
0.66
US$3,762,000 		5,700,000 +323.5% 0.66 US$3,762,000
2013-01-29 2013-01-25 B Purchase ORBIMED ADVISORS LLC Non-Executive Director
1,762,000 +inf%
0.65
US$1,142,481 		1,762,000 +inf% 0.65 US$1,142,481
2012-07-03 2012-06-29 S Sale ORBIMED ADVISORS LLC Non-Executive Director
1,283,300 -100.0%
0.73
US$942,071 		1,283,300 -100.0% 0.73 US$942,071
2012-07-02 2012-06-29 B Purchase HENNEY CHRISTOPHER S Non-Executive Director
100,000 +inf%
0.75
US$74,930 		100,000 +inf% 0.75 US$74,930
2012-07-02 2012-06-29 B Purchase HENNEY CHRISTOPHER S Non-Executive Director
100,000 +97.6%
0.75
US$74,930 		100,000 +97.6% 0.75 US$74,930
2012-07-02 2012-06-29 B Purchase TRUEX PAUL F

President and CEO

Executive Director
20,000 +3.2%
0.76
US$15,200 		20,000 +3.2% 0.76 US$15,200
2012-03-22 2012-03-22 S Sale ORBIMED ADVISORS LLC Non-Executive Director
1,306,700 -50.5%
2.40
US$3,140,131 		1,306,700 -50.5% 2.40 US$3,140,131
2012-03-22 2012-03-21 S Sale ORBIMED ADVISORS LLC Non-Executive Director
125,000 -4.6%
2.87
US$358,312 		125,000 -4.6% 2.87 US$358,312
2012-03-22 2012-03-20 S Sale ORBIMED ADVISORS LLC Non-Executive Director
116,800 -4.1%
2.90
US$338,638 		116,800 -4.1% 2.90 US$338,638
2012-01-03 2011-12-30 S Sale HEALY JAMES Non-Executive Director Large shareholder
280 -0.6%
6.23
US$1,743 		280 -0.6% 6.23 US$1,743
2012-01-03 2011-12-30 S Sale HEALY JAMES Non-Executive Director Large shareholder
4,090 -0.6%
6.23
US$25,460 		4,090 -0.6% 6.23 US$25,460
2012-01-03 2011-12-30 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
280 -0.6%
6.23
US$1,743 		280 -0.6% 6.23 US$1,743
2012-01-03 2011-12-30 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
4,090 -0.6%
6.23
US$25,460 		4,090 -0.6% 6.23 US$25,460
2012-01-03 2011-12-30 S Sale HEALY JAMES Non-Executive Director Large shareholder
20,630 -0.6%
6.23
US$128,422 		20,630 -0.6% 6.23 US$128,422
2012-01-03 2011-12-30 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
20,630 -0.6%
6.23
US$128,422 		20,630 -0.6% 6.23 US$128,422
2011-12-23 2011-12-22 S Sale HEALY JAMES Non-Executive Director Large shareholder
280 -0.6%
6.22
US$1,743 		280 -0.6% 6.22 US$1,743
2011-12-23 2011-12-22 S Sale HEALY JAMES Non-Executive Director Large shareholder
4,090 -0.6%
6.22
US$25,457 		4,090 -0.6% 6.22 US$25,457
2011-12-23 2011-12-22 S Sale HEALY JAMES Non-Executive Director Large shareholder
20,630 -0.6%
6.22
US$128,405 		20,630 -0.6% 6.22 US$128,405
2011-12-23 2011-12-22 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
280 -0.6%
6.22
US$1,743 		280 -0.6% 6.22 US$1,743
2011-12-23 2011-12-22 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
4,090 -0.6%
6.22
US$25,457 		4,090 -0.6% 6.22 US$25,457
2011-12-23 2011-12-22 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
20,630 -0.6%
6.22
US$128,405 		20,630 -0.6% 6.22 US$128,405
2011-12-23 2011-12-21 S Sale HEALY JAMES Non-Executive Director Large shareholder
280 -0.6%
6.51
US$1,823 		280 -0.6% 6.51 US$1,823
2011-12-23 2011-12-21 S Sale HEALY JAMES Non-Executive Director Large shareholder
4,090 -0.6%
6.51
US$26,629 		4,090 -0.6% 6.51 US$26,629
2011-12-23 2011-12-21 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
280 -0.6%
6.51
US$1,823 		280 -0.6% 6.51 US$1,823
2011-12-23 2011-12-21 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
4,090 -0.6%
6.51
US$26,629 		4,090 -0.6% 6.51 US$26,629
2011-12-23 2011-12-21 S Sale HEALY JAMES Non-Executive Director Large shareholder
20,630 -0.6%
6.51
US$134,318 		20,630 -0.6% 6.51 US$134,318
2011-12-23 2011-12-21 S Sale SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
20,630 -0.6%
6.51
US$134,318 		20,630 -0.6% 6.51 US$134,318
2011-12-13 2011-12-13 S Sale ORBIMED ADVISORS LLC Non-Executive Director
16,200 -0.6%
6.50
US$105,300 		16,200 -0.6% 6.50 US$105,300
2011-12-13 2011-12-09 S Sale ORBIMED ADVISORS LLC Non-Executive Director
40,000 -1.4%
6.75
US$270,000 		40,000 -1.4% 6.75 US$270,000
2011-11-18 2011-11-18 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
3,000 -0.1%
6.50
US$19,500 		3,000 -0.1% 6.50 US$19,500
2011-11-18 2011-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
24,000 -0.8%
6.67
US$160,080 		24,000 -0.8% 6.67 US$160,080
2011-11-18 2011-11-16 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
25,000 -0.9%
6.87
US$171,750 		25,000 -0.9% 6.87 US$171,750
2011-11-17 2011-11-15 PlS Planned sale TRUEX PAUL F

President and CEO

Executive Director
15,000 -2.2%
6.96
US$104,352 		15,000 -2.2% 6.96 US$104,352
2011-11-17 2011-11-15 PlS Planned sale TRUEX PAUL F

President and CEO

Executive Director
15,000 -2.2%
6.96
US$104,352 		15,000 -2.2% 6.96 US$104,352
2011-11-15 2011-11-15 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
50,000 -1.7%
6.93
US$346,500 		50,000 -1.7% 6.93 US$346,500
2011-11-15 2011-11-14 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
5,000 -0.2%
6.95
US$34,750 		5,000 -0.2% 6.95 US$34,750
2011-11-15 2011-11-11 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
5,000 -0.2%
7.14
US$35,700 		5,000 -0.2% 7.14 US$35,700
2011-11-10 2011-11-08 S Sale Hislop Colin

Chief Medical Officer

Officer
15,000 -20.6%
6.74
US$101,163 		15,000 -20.6% 6.74 US$101,163
2011-10-25 2011-10-21 PlS Planned sale TRUEX PAUL F

President and CEO

Executive Director
11,879 -1.8%
6.25
US$74,244 		11,879 -1.8% 6.25 US$74,244
2011-08-04 2011-08-02 PlS Planned sale LOWE CHRISTOPHER P.

Chief Financial Officer & CBO

Officer
300 -6.1%
7.93
US$2,378 		300 -6.1% 7.93 US$2,378
2011-06-20 2011-06-16 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
10 -0.1%
8.67
US$87 		10 -0.1% 8.67 US$87
2011-06-20 2011-06-16 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
281 -0.1%
8.67
US$2,436 		281 -0.1% 8.67 US$2,436
2011-06-20 2011-06-16 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
2,809 -0.1%
8.67
US$24,354 		2,809 -0.1% 8.67 US$24,354
2011-06-17 2011-06-15 PlS Planned sale TRUEX PAUL F

President and CEO

Executive Director
15,000 -2.2%
8.30
US$124,539 		15,000 -2.2% 8.30 US$124,539
2011-06-15 2011-06-14 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
2 -0.0%
8.81
US$18 		2 -0.0% 8.81 US$18
2011-06-15 2011-06-14 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
63 -0.0%
8.81
US$555 		63 -0.0% 8.81 US$555
2011-06-15 2011-06-14 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
634 -0.0%
8.81
US$5,586 		634 -0.0% 8.81 US$5,586
2011-06-15 2011-06-13 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
4 -0.0%
8.80
US$35 		4 -0.0% 8.80 US$35
2011-06-15 2011-06-13 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
118 -0.0%
8.80
US$1,038 		118 -0.0% 8.80 US$1,038
2011-06-15 2011-06-13 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
1,178 -0.0%
8.80
US$10,366 		1,178 -0.0% 8.80 US$10,366
2011-06-10 2011-06-10 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
30,000 -1.0%
8.18
US$245,400 		30,000 -1.0% 8.18 US$245,400
2011-06-10 2011-06-09 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
37,000 -1.2%
8.11
US$300,070 		37,000 -1.2% 8.11 US$300,070
2011-06-10 2011-06-08 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
33,000 -1.1%
8.02
US$264,660 		33,000 -1.1% 8.02 US$264,660
2011-05-31 2011-05-26 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
16 -0.1%
8.60
US$138 		16 -0.1% 8.60 US$138
2011-05-31 2011-05-26 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
435 -0.1%
8.60
US$3,741 		435 -0.1% 8.60 US$3,741
2011-05-31 2011-05-26 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
4,349 -0.1%
8.60
US$37,401 		4,349 -0.1% 8.60 US$37,401
2011-05-27 2011-05-25 S Sale ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
4,800
8.65
US$41,520 		4,800 8.65 US$41,520
2011-05-25 2011-05-25 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
108 -0.6%
8.67
US$936 		108 -0.6% 8.67 US$936
2011-05-25 2011-05-25 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
2,970 -0.6%
8.67
US$25,750 		2,970 -0.6% 8.67 US$25,750
2011-05-25 2011-05-25 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
29,672 -0.6%
8.67
US$257,256 		29,672 -0.6% 8.67 US$257,256
2011-05-25 2011-05-24 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
172 -1.0%
8.42
US$1,448 		172 -1.0% 8.42 US$1,448
2011-05-25 2011-05-24 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
4,734 -1.0%
8.42
US$39,860 		4,734 -1.0% 8.42 US$39,860
2011-05-25 2011-05-24 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
47,290 -1.0%
8.42
US$398,182 		47,290 -1.0% 8.42 US$398,182
2011-05-25 2011-05-23 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
88 -0.5%
8.18
US$720 		88 -0.5% 8.18 US$720
2011-05-25 2011-05-23 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
2,422 -0.5%
8.18
US$19,812 		2,422 -0.5% 8.18 US$19,812
2011-05-25 2011-05-23 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
24,193 -0.5%
8.18
US$197,899 		24,193 -0.5% 8.18 US$197,899
2011-05-19 2011-05-19 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
412 -2.2%
8.03
US$3,308 		412 -2.2% 8.03 US$3,308
2011-05-19 2011-05-19 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
11,337 -2.2%
8.03
US$91,036 		11,337 -2.2% 8.03 US$91,036
2011-05-19 2011-05-19 S Sale VANTAGEPOINT VENTURE ASSOCIATES IV LLC Large shareholder
113,251 -2.2%
8.03
US$909,406 		113,251 -2.2% 8.03 US$909,406
Explore more

More insider trading research around Anthera Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America